The Legal 500

Arnold Bloch Leibler

LEVEL 21, 333 COLLINS STREET, MELBOURNE, VICTORIA 3000, AUSTRALIA
Tel:
Work +61 3 9229 9999
Fax:
Fax +61 3 9229 9900
Email:
Web:
www.abl.com.au
Sydney, Melbourne

Australia

Recommendations


Australia

Within Banking and finance, Arnold Bloch Leibler is a third tier firm,

Arnold Bloch Leibler’s ‘highly commercial and outcome-focused’ team includes Genevieve Sexton, who has ‘vast experience of handling multi-jurisdictional transactions, and is engaging to work with’. Ben Mahoney advised Royal Bank of Canada on a syndicated financing facility relating to the A$1.4bn divestment of Civeo Corp by Oil States.

[back to top]

Within Capital markets, tier 4

At Arnold Bloch Leibler, respected corporate lawyer Jeremy Leibler acted for Hotel Property Investments on its A$279m IPO. The firm also handled a number of convertible bond issuances, including Indus Coal Limited’s A$4m placement of secured convertible bonds. Jonathan Wenig is recommended. Rick Narev joined Addisons.

[back to top]

Within Competition and trade, tier 4

At Arnold Bloch Leibler, ‘master tacticianZaven Mardirossian heads a practice that handles competition and IP issues. As well as providing merger advice to major online businesses, the team has also handled a number of ACCC investigations. Matthew Lees is also recommended.

[back to top]

Within Corporate and M&A, tier 4

The ‘routinely excellentArnold Bloch Leibler stands out for its ‘timely and practical advice’. Practice head Jonathan Wenig advised carsales.com on its A$89m bid for 30% of WebMotors. Jeremy Leibler is also recommended.

[back to top]

Within Dispute resolution, Arnold Bloch Leibler is a second tier firm,

Arnold Bloch Leibler’s clients appreciate its ‘finely honed commercial intuition’. Leon Zwier (who ‘gives his clients an advantage in complex disputes’) defended Pacific Equity Partners in allegations by Asahi Holdings of misleading conduct during a sale process. Jonathan Milner has ‘excellent commercial sense’, and Justin Vaatstra is ‘exceptionally astute’.

[back to top]

Within Employment, tier 5

James Simpson leads the team at Arnold Bloch Leibler, and is praised for his ‘technical knowledge, attention to detail and collaborative approach’. The practice has particular expertise in international employment issues, and is acting for Valuair Limited in relation to a prosecution brought by the Fair Work Ombudsman.

[back to top]

Within Intellectual property, tier 4

Arnold Bloch Leibler’s Zaven Mardirossian is ‘a master tactician’, and Matthew Lees is ‘very commercial, with great technical skills’. Clients include Beyond International, Just Group and carsales.com.

[back to top]

Within Real estate, tier 5

Arnold Bloch Leibler attracts praise for its ‘in-depth industry knowledge and value for money’. Practice head Ken Gray is ‘intuitive to clients’ requirements’, and Jonathan Caplan’s ‘business acumen sets him apart’. Lily Tell left the practice.

[back to top]

Within Restructuring and insolvency, Arnold Bloch Leibler is a second tier firm,

At Arnold Bloch Leibler, leading practitioner Leon Zwier is praised as being a ‘great lawyer, someone who gets deals done without resorting to points scoring’. Zwier recently acted on behalf of the senior lenders in the restructuring of Nine Entertainment. Ben Mahoney is also recommended.

[back to top]

Within Tax, Arnold Bloch Leibler is a second tier firm,

Arnold Bloch Leibler’s practice is headed by Mark Leibler, who is lauded for his ‘razor-sharp skills for listening to others and getting to the crux of an issue’. The team, which advises individuals, private company groups and publicly listed companies, has particular strength in the management of taxation disputes arising from Australian Taxation Office (ATO) compliance activities and audits. Paul Sokolowski and Ross Paterson are also recommended

[back to top]


Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • China Drug Registration Regulation - Public consultation on amendment closes - March 2014

    In February 2014, the China Food and Drug Administration (“CFDA”) invited second-round comments from the public regarding proposed amendments to the China Drug Registration Regulations (“DRR”). One of the proposed amendments touches upon patent protection for drugs in China.
  • Revised NDRC Measures for Approval and Filing of Outbound Investment Projects - April 2014

    The National Development and Reform Commission ( NDRC ) released a new set of Management Measures for Approval and Filing of Outbound Investment Projects ( 境外投资项目核准和备案管理办法) ( New Measures ) on 8 April 2014. The New Measures take effect on 8 May 2014 and will replace the Interim Management Measures for Approval of Outbound Investment Projects ( 境外投资项目核准暂行管理办法) ( Original Measures ) which have been in force since 9 October 2004.
  • Insurance Update - CIRC Issues Insurance M&A Measures: What are the impacts and applications?

    On 21 March 2014, CIRC issued the Administrative Measures on the Acquisition and Merger of Insurance Companies (the Insurance M&A Measures ) which will take effect from 1 June 2014. The Insurance M&A Measures apply to M&A activities whereby an insurance company is the target for a merger or acquisition. The target insurance company could be either a domestic or a foreign invested insurer. However, the Insurance M&A Measures will not apply to any equity investment by insurance companies in non-insurance companies in China or in overseas insurance companies.
  • China issues new rules to regulate medical devices - May 2014

    The Regulations on Supervision and Administration of Medical Devices (in Chinese《医疗器械监督管理条例》, State Council Order No. 650) (the Medical Device Regulations) were amended by China's State Council on 31 March 2014 and will come into effect on 1 June 2014. This is the first amendment in more than a decade since the Medical Device Regulations were first promulgated in 2000, even though the amendment was initiated eight years ago in 2006. The 2014 amendment unveils reforms on the regulatory regime for medical devices market in China from various aspects.
  • Walking a fine line in China:Distinguishing between legitimate commercial deals and commercial bribe

    China in the 21st century exemplifies an atmosphere of great opportunity and intense competition. Against this backdrop, it has become increasingly common for businesses to adopt a variety of practices in order to make their products and services competitive. Such practices may include paying middle-men to promote sales and giving incentives to buyers directly. However, whilst revenue spikes are undoubtedly welcome, businesses should bear in mind the potential backlash arising out of these commercial arrangements. The risk that such arrangements may not comply with anti-bribery and corruption laws and therefore cause business significant damage in the long term should not be underestimated.
  • Rise of the private healthcare sector - July 2014

    As of 2013, China had 9,800 private hospitals, representing almost half of the total number of hospitals in the country 1 . However, private hospitals still severely lag behind their public peers due to low utilisation, talent shortages and incomplete social insurance coverage. As part of China's ongoing healthcare reform initiatives, the Chinese government has set a goal to increase the share of patients treated by private hospitals to 20% by the end of 2015 2 .
  • Banking regulation in China: Proposed deposit insurance system - December 2014

    On 30 November 2014, the State Council of China released a draft Deposit Insurance Regulation (the Draft), to establish a deposit insurance system in order to "protect interests of depositors, prevent and mitigate financial risks and maintain a stabilised financial system". The public are invited to submit comments on the Draft by 30 December 2014.
  • Tackling bribery: China toughens criminal law - December 2014

    Following earlier reforms of the PRC's anti-corruption rules (for further information, please see our previous briefings published in January 2013 and March 2011 ), the National People's Congress (NPC) has recently published a proposed amendment to the PRC Criminal Law in draft form for public comments (the Draft). The Draft expands the reach of official bribery offences, gives more autonomy to judges to inflict severe punishments, and generally increases the level and type of punishments that can be imposed on individuals who commit bribery offences. It further demonstrates the government's determination to tackle corruption in China.
  • China banking restrictions relaxed: New rules further open banking sector to foreign investors

    The State Council of China recently released amendments to the Foreign Bank Administrative Regulations of China (the Amendments) with effect from 1 January 2015.
  • Walking a Tightrope in Singapore - July 2014

    The world has no borders and distance is negligible for the technologically savvy criminal. Individuals with illicit funds to launder or terrorist activities to finance can, with the latest technology, transfer high volumes of money around the globe almost instantaneously and seek to conceal the origin or the destination of the funds.